Oncothyreon (ONTY +2.1%) announces the filing of an Investigational New Drug application with...

|By:, SA News Editor

Oncothyreon (ONTY +2.1%) announces the filing of an Investigational New Drug application with the FDA for ONT-10, a therapeutic vaccine directed at cancers expressing MUC1. Upon completion of the review, expects to initiate a Phase 1 trials.